Trupanion AI Stock Analysis
Want to see TRUP full AI Analyst Report?
Trupanion (TRUP) AI Stock Analysis
Trupanion
(NASDAQ:TRUP)
The score is driven primarily by improving financial performance and cash flow alongside a very positive earnings outlook (record profitability/cash flow and raised guidance). Technicals support the trend but are overextended (very high RSI/Stoch), and the high P/E with no dividend yield meaningfully tempers the overall rating.
Trupanion Key Performance Indicators (KPIs)
Gross Profit by SegmentShows profitability across different business areas, highlighting which segments drive earnings and where there may be opportunities or challenges.
Subscription gross profit is the clear earnings engine: improving per‑pet economics, a better loss ratio and automation have driven sustained margin expansion and created the AOI that management is redeploying into disciplined pet acquisition and product rollout. The “Other” line is small and volatile—recent partner enrollment headwinds have capped its contribution—so Trupanion’s upside depends on sustaining subscription pricing/retention and controlling rising acquisition costs and reserve variability, which are the main near‑term risks to continued gross profit momentum.
Trupanion (TRUP) vs. SPDR S&P 500 ETF (SPY)
- Market Cap
- $1.59B
- Dividend Yield
- ―
- Average Volume (3M)
- 435.76K
- Price to Earnings (P/E)
- 60.1
- Beta (1Y)
- 0.99
- Revenue Growth
- 11.41%
- EPS Growth
- 70.52%
- Country
- US
- Employees
- 1,121
- Sector
- Financial
- Sector Strength
- 68
- Industry
- Insurance - Property & Casualty
Trupanion Business Overview & Revenue Model
Company Description
Trupanion, Inc. provides monthly subscription-based medical insurance for canine and feline companions across the United States, Canada, Puerto Rico, and Australia. The company's operations are divided into two main categories: Subscription Business...
How the Company Makes Money
Trupanion makes money primarily by selling and administering pet medical insurance policies and collecting recurring premium revenue from enrolled pet owners. The core revenue stream is subscription-like insurance premiums (typically paid monthly) fo...
Trupanion Earnings Call Summary
The call was strongly positive, with record adjusted operating income and free cash flow, continued growth in pets and retention, improved acquisition efficiency, expanding technology and AI capabilities, and an increased full-year outlook. The company also acknowledged lower subscription value proposition, elevated double-digit cost inflation, higher fixed expenses, the planned Pets Best runoff, and limited near-term Landspath revenue, but these challenges were outweighed by the reported operating momentum and financial performance.
Q3-2026 Updates
Positive Updates
Negative Updates
Company Guidance
For the full year of 2026, Trupanion expects total revenue in the range of $1.59 billion to $1.597 billion, subscription revenue between $1.131 billion and $1.133 billion, and total adjusted operating income between $179 million and $182 million, or 19% year over year growth at the midpoint; for the fourth quarter of 2026, total revenue is expected in the range of $407 million to $414 million, subscription revenue between $297 million and $299 million, representing approximately 14% year over year growth at the midpoint, and total adjusted operating income in the range of $48 million to $51 million, representing approximately 10% growth year over year at the midpoint, with projections using a 72% conversion rate; management expects continuous double-digit inflation in 2027, said pricing assumes that, and anticipates average member increase to continue to ease off in 2027.
Trupanion Financial Statement Overview
Summary
Financials show a clear turnaround with improving profitability (positive net income/ROE after prior losses) and strong recent cash generation (solid TTM operating cash flow and free cash flow with good earnings-to-cash support). Offsetting this, profitability remains thin and gross margin has been volatile, implying sensitivity to underwriting/claims dynamics and cost control.
Income Statement
72PositiveBalance Sheet
74PositiveCash Flow
80Positive| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.56B | 1.44B | 1.29B | 1.11B | 905.18M | 698.99M |
| Gross Profit | 351.28M | 410.33M | 178.80M | 131.02M | 122.19M | 104.35M |
| EBITDA | 54.70M | 51.59M | 21.33M | -20.48M | -29.01M | -23.25M |
| Net Income | 26.62M | 19.43M | -9.63M | -44.69M | -44.67M | -35.53M |
Balance Sheet | ||||||
| Total Assets | 921.62M | 915.04M | 806.85M | 782.95M | 671.63M | 562.58M |
| Cash, Cash Equivalents and Short-Term Investments | 396.84M | 370.73M | 307.38M | 277.17M | 222.41M | 213.41M |
| Total Debt | 104.47M | 111.78M | 128.89M | 128.93M | 69.46M | 0 |
| Total Liabilities | 522.42M | 531.11M | 483.58M | 479.23M | 366.33M | 230.38M |
| Stockholders Equity | 399.20M | 383.94M | 323.27M | 303.72M | 305.30M | 332.20M |
Cash Flow | ||||||
| Free Cash Flow | 86.71M | 75.36M | 38.57M | 358.00K | -25.09M | -4.90M |
| Operating Cash Flow | 95.55M | 89.49M | 48.29M | 18.64M | -8.00M | 7.46M |
| Investing Cash Flow | -45.92M | -95.89M | -13.46M | 7.64M | -67.52M | -51.91M |
| Financing Cash Flow | -38.44M | -22.86M | -3.96M | 59.13M | 60.74M | -1.13M |
Trupanion Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For TRUP, the sentiment is Positive. The current price of 35.87 is above the 20-day moving average (MA) of 32.87, above the 50-day MA of 28.34, and above the 200-day MA of 26.75, indicating a bullish trend. The MACD of 2.28 indicates Negative momentum. The RSI at 74.57 is Negative, neither overbought nor oversold. The STOCH value of 67.23 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for TRUP.
Trupanion Risk Analysis
Trupanion disclosed 112 risk factors in its most recent earnings report. Trupanion reported the most risks in the "Finance & Corporate" category.
Latest Risks Added
3 New RisksTrupanion Peers Comparison
Overall Rating
AFG84Outperform
CB84Outperform
PGR83Outperform
ERIE82Outperform
TRUP71Outperform
LMND54Neutral
Financial Indicators
| Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
| 84Outperform | $13.07B | 12.87 | 21.42% | 4.40% | 2.13% | 28.64% | |
| 84Outperform | $141.76B | 12.89 | 15.06% | 1.07% | 5.89% | 19.00% | |
| 83Outperform | $132.37B | 11.48 | 35.44% | 6.08% | 7.65% | 8.90% | |
| 82Outperform | $12.71B | 22.33 | 23.86% | 2.12% | 1.97% | -11.09% | |
| 71Outperform | $1.59B | 60.13 | 6.71% | ― | 11.41% | 70.52% | |
| Sector * | 68Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% |
| 54Neutral | $3.07B | -20.49 | -28.59% | ― | 89.43% | 20.78% |
* Financial Sector Average
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| TRUP | Trupanion Inc. | 35.87 | -0.03 | -0.08% | |
| CB | Chubb Ltd | 370.11 | 75.45 | 25.61% | |
| AFG | American Financial | 156.87 | 26.65 | 20.47% | |
| ERIE | Erie Indemnity | 268.94 | -20.59 | -7.11% | |
| PGR | The Progressive Corporation | 229.96 | 16.91 | 7.94% | |
| LMND | Lemonade Inc | 38.22 | -29.13 | -43.25% |
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.
Date of analysis: Nov 06, 2026
